SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-98-001503
Filing Date
1998-11-16
Accepted
1998-11-16 00:00:00
Documents
9
Period of Report
1998-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 107671
2 EXHIBIT 10.1 EX-10.1 17460
3 EXHIBIT 10.2 EX-10.2 4893
4 EXHIBIT 10.3 EX-10.3 2185
5 EXHIBIT 10.4 EX-10.4 3525
6 EXHIBIT 10.5 EX-10.5 61072
7 EXHIBIT 10.6 EX-10.6 57008
8 EXHIBIT 10.7 EX-10.7 7987
9 FINANCIAL DATA SCHEDULE EX-27.1 2763
  Complete submission text file 0000936392-98-001503.txt   266717
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 6195353900
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 98749591
SIC: 2834 Pharmaceutical Preparations